Q-Linea AB
Q-linea is a Swedish company dedicated to improving sepsis treatment and safeguarding the effectiveness of antibiotics through innovative infection diagnostics. Since its founding in 2008, it has developed advanced solutions such as the CE-IVDR marked ASTar system, a rapid and automated antimicrobial susceptibility testing platform. The company focuses on clinical impact, rapid diagnostics, and supporting antimicrobial stewardship programs worldwide.
Industries
Nr. of Employees
small (1-50)
Q-Linea AB
Dag Hammarskjölds väg 52 A, SE-752 37 Uppsala, Sweden
Patents
Method for determining the concentration of intact microorganisms in a sample
US-12241113-B2
View Details
Method for determining the concentration of intact microorganisms in a sample
US-12241113-B2
View DetailsProducts
Fully automated rapid phenotypic AST benchtop system
Benchtop diagnostic instrument that automates sample preparation and broth microdilution-based phenotypic susceptibility testing to deliver MIC values and SIR categorisation rapidly (≈6 hours) with continuous random access.
Consumable kit: sample preparation cartridge and AST disc with frozen insert
Single-use consumable kit comprising a cartridge with pre-deposited reagents and a frozen insert, and an AST disc containing hundreds of culturing chambers pre-filled with antimicrobials at multiple concentrations; barcoded for traceability.
Fully automated rapid phenotypic AST benchtop system
Benchtop diagnostic instrument that automates sample preparation and broth microdilution-based phenotypic susceptibility testing to deliver MIC values and SIR categorisation rapidly (≈6 hours) with continuous random access.
Consumable kit: sample preparation cartridge and AST disc with frozen insert
Single-use consumable kit comprising a cartridge with pre-deposited reagents and a frozen insert, and an AST disc containing hundreds of culturing chambers pre-filled with antimicrobials at multiple concentrations; barcoded for traceability.
Services
Phone and email-based technical assistance for instrument operation, consumables and software; access to a technical library via customer portal.
On-site and remote product demos and participation in planned clinical evaluations for prospective hospital and laboratory customers.
Regional distribution network management and partnership agreements to expand market reach in targeted geographies.
Phone and email-based technical assistance for instrument operation, consumables and software; access to a technical library via customer portal.
On-site and remote product demos and participation in planned clinical evaluations for prospective hospital and laboratory customers.
Regional distribution network management and partnership agreements to expand market reach in targeted geographies.
Expertise Areas
- Rapid antimicrobial susceptibility testing
- Clinical validation and HEOR for diagnostics
- Diagnostic laboratory automation
- Consumable design for in vitro diagnostics
Key Technologies
- Phenotypic antimicrobial susceptibility testing
- Broth microdilution
- Controlled inoculum generation
- Automated sample-preparation cartridges
News & Updates
A presentation by Stuart Gander, CEO, at the Redeye Medtech event.
CEO Stuart Gander presents at the Redeye Medtech event on May 7, 2025.
Q-linea has demonstrated clinical benefits of its ASTar system, including reducing time-to-result and supporting antimicrobial stewardship.
Founded in 2008 in Uppsala, Sweden, Q-linea has grown into an international team focused on improving sepsis diagnostics.
Q-linea is certified under ISO 13485:2016, ensuring quality management for medical devices.
A presentation by Stuart Gander, CEO, at the Redeye Medtech event.
CEO Stuart Gander presents at the Redeye Medtech event on May 7, 2025.
Q-linea has demonstrated clinical benefits of its ASTar system, including reducing time-to-result and supporting antimicrobial stewardship.
Founded in 2008 in Uppsala, Sweden, Q-linea has grown into an international team focused on improving sepsis diagnostics.
Q-linea is certified under ISO 13485:2016, ensuring quality management for medical devices.